SMTL ID : 4c66.1

Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.87 Å

Oligo State

monomer

Ligands

1 x H4C: 4-(2-chlorophenyl)-2-ethyl-9-methyl-6,8-dihydrothieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-10-ium(Non-covalent)

H4C.1: 10 residues within 4Å: Chain A: W.40, P.41, F.42, Q.44, V.46, L.51, L.53, N.99, I.105, M.108 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:W.40, A:W.40, A:F.42, A:V.46, A:L.51, A:I.105 Hydrogen bonds: A:N.99 Water bridges: A:Y.56

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mirguet, O. et al., Discovery of Epigenetic Regulator I-Bet762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the Bet Bromodomains. J.Med.Chem. (2013)

Release Date

2013-10-02

Peptides

BROMODOMAIN-CONTAINING PROTEIN 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

BROMODOMAIN-CONTAINING PROTEIN 4